This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProduction, part of CPhI Barcelona
8-10 October 2024
Milan

Prestige Biopharma

Profile

Prestige BioPharma is a Singapore-based biopharmaceutical company focusing on the development of biosimilars and new antibody therapeutics. Its lead program, HD201 trastuzumab biosimilar, has been filed with EMA in April 2019 and will also be filed with USFDA in 2019. Prestige BioPharma’s next products in line include a Bevacizumab biosimilar.